Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism

Toxicology Letters

Volumn 197, Issue 3, 2010, Pages 201-210

  Zhao, Qing ^a   Wang, Jia ^a   Zou, Mei Juan ^a   Hu, Rong ^a   Zhao, Li ^a   Qiang, Lei ^a   Rong, Jing Jing ^a   You, Qi Dong ^a   Guo, Qing Long ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Gastric cancer; NF BDPD; Synergism; Wogonin

Indexed keywords

CASPASE 3; DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; WOGONIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL NUCLEUS; CELL VIABILITY; CELLULAR DISTRIBUTION; DOWN REGULATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RETENTION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOMACH CANCER; WEIGHT REDUCTION;

ANIMALIA;

EID: 77954959058     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.05.019     Document Type: Article

References (47)

1. Adams E.R., Leffert J.J., Craig D.J., Spector T., Pizzorno G. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy. Cancer Res. 1999, 59:122-127.
2. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004, 6:203-208.
3. Ajani J.A. Evolving chemotherapy for advanced gastric cancer. Oncologist 2005, 10(Suppl. 3):49-58.
4. Cao S.S., Zhen Y.S. Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B. Cancer Chemother. Pharmacol. 1989, 24:181-186.
5. Cervantes A., Rosello S., Roda D., Rodriguez-Braun E. The treatment of advanced gastric cancer: current strategies and future perspectives. Ann. Oncol. 2008, 19(Suppl. 5):v103-v107.
6. Chang W.H., Chen C.H., Lu F.J. Different effects of baicalein, baicalin and wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines. Planta Med. 2002, 68:128-132.
7. Chi Y.S., Lim H., Park H., Kim H.P. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem. Pharmacol. 2003, 66:1271-1278.
8. Chou T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 2006, 58:621-681.
9. Chou T.C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 1984, 22:27-55.
10. Debatin K.M., Krammer P.H. Death receptors in chemotherapy and cancer. Oncogene 2004, 23:2950-2966.
11. Diasio R.B. The role of dihydropyrimidine dehydrogenase (DPD) modulation in 5-FU pharmacology. Oncology (Williston Park) 1998, 12:23-27.
12. Etienne M.C., Chazal M., Laurent-Puig P., Magne N., Rosty C., Formento J.L., Francoual M., Formento P., Renee N., Chamorey E., Bourgeon A., Seitz J.F., Delpero J.R., Letoublon C., Pezet D., Milano G. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J. Clin. Oncol. 2002, 20:2832-2843.
13. Fujiwara H., Terashima M., Irinoda T., Takagane A., Abe K., Nakaya T., Yonezawa H., Oyama K., Takahashi M., Saito K., Takechi T., Fukushima M., Shirasaka T. Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity. Eur. J. Cancer 2003, 39:2387-2394.
14. Fukushima M., Fujioka A., Uchida J., Nakagawa F., Takechi T. Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo. Eur. J. Cancer 2001, 37:1681-1687.
15. Galluzzi L., Larochette N., Zamzami N., Kroemer G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 2006, 25:4812-4830.
16. Garg A.K., Buchholz T.A., Aggarwal B.B. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid. Redox Signal. 2005, 7:1630-1647.
17. Glimelius B., Hoffman K., Haglund U., Nyren O., Sjoden P.O. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann. Oncol. 1994, 5:189-190.
18. Guo Q., Zhao L., You Q., Yang Y., Gu H., Song G., Lu N., Xin J. Anti-hepatitis B virus activity of wogonin in vitro and in vivo. Antiviral Res. 2007, 74:16-24.
19. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
20. Heggie G.D., Sommadossi J.P., Cross D.S., Huster W.J., Diasio R.B. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res. 1987, 47:2203-2206.
21. Hui K.M., Huen M.S., Wang H.Y., Zheng H., Sigel E., Baur R., Ren H., Li Z.W., Wong J.T., Xue H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem. Pharmacol. 2002, 64:1415-1424.
22. Ikemoto S., Sugimura K., Yoshida N., Yasumoto R., Wada S., Yamamoto K., Kishimoto T. Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 2000, 55:951-955.
23. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 2006, 24:2137-2150.
24. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
25. Kim H., Kim Y.S., Kim S.Y., Suk K. The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neurosci. Lett. 2001, 309:67-71.
26. Lee W.R., Shen S.C., Lin H.Y., Hou W.C., Yang L.L., Chen Y.C. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochem. Pharmacol. 2002, 63:225-236.
27. Liu Z.L., Tanaka S., Horigome H., Hirano T., Oka K. Induction of apoptosis in human lung fibroblasts and peripheral lymphocytes in vitro by Shosaiko-to derived phenolic metabolites. Biol. Pharm. Bull. 2002, 25:37-41.
28. Longley D.B., Boyer J., Allen W.L., Latif T., Ferguson P.R., Maxwell P.J., McDermott U., Lynch M., Harkin D.P., Johnston P.G. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates. Cancer Res. 2002, 62:2644-2649.
29. Lu N., Gao Y., Ling Y., Chen Y., Yang Y., Gu H.Y., Qi Q., Liu W., Wang X.T., You Q.D., Guo Q.L. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2. Life Sci. 2008, 82:956-963.
30. Mori K., Hasegawa M., Nishida M., Toma H., Fukuda M., Kubota T., Nagasue N., Yamana H., Hirakawa Y.S.C.K., Ikeda T., Takasaki K., Oka M., Kameyama M., Toi M., Fujii H., Kitamura M., Murai M., Sasaki H., Ozono S., Makuuchi H., Shimada Y., Onishi Y., Aoyagi S., Mizutani K., Ogawa M., Nakao A., Kinoshita H., Tono T., Imamoto H., Nakashima Y., Manabe T. Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int. J. Oncol. 2000, 17:33-38.
31. Nobili S., Lippi D., Witort E., Donnini M., Bausi L., Mini E., Capaccioli S. Natural compounds for cancer treatment and prevention. Pharmacol. Res. 2009, 59:365-378.
32. Qi Q., Peng J., Liu W., You Q., Yang Y., Lu N., Wang G., Guo Q. Toxicological studies of wogonin in experimental animals. Phytother. Res. 2009, 23:417-422.
33. Rocco A., Nardone G. Diet, H. pylori infection and gastric cancer: evidence and controversies. World J. Gastroenterol. 2007, 13:2901-2912.
34. Shieh D.E., Liu L.T., Lin C.C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res. 2000, 20:2861-2865.
35. Son D., Lee P., Lee J., Kim H., Kim S.Y. Neuroprotective effect of wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation. Eur. J. Pharmacol. 2004, 493:99-102.
36. Spears C.P., Shahinian A.H., Moran R.G., Heidelberger C., Corbett T.H. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res. 1982, 42:450-456.
37. Wada Y., Yoshida K., Suzuki T., Mizuiri H., Konishi K., Ukon K., Tanabe K., Sakata Y., Fukushima M. Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines. Int. J. Cancer 2006, 119:783-791.
38. Wang W., Cassidy J. Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells. Br. J. Cancer 2003, 88:624-629.
39. Wang W., Cassidy J., O'Brien V., Ryan K.M., Collie-Duguid E. Mechanistic and predictive profiling of 5-fluorouracil resistance in human cancer cells. Cancer Res. 2004, 64:8167-8176.
40. Wang W., Collie-Duguid E., Cassidy J. Cerivastatin enhances the cytotoxicity of 5-fluorouracil on chemosensitive and resistant colorectal cancer cell lines. FEBS Lett. 2002, 531:415-420.
41. Wang W., Guo Q.L., You Q.D., Zhang K., Yang Y., Yu J., Liu W., Zhao L., Gu H.Y., Hu Y., Tan Z., Wang X.T. The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo. Biol. Pharm. Bull. 2006, 29:1132-1137.
42. Wang W., Marsh S., Cassidy J., McLeod H.L. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors. Cancer Res. 2001, 61:5505-5510.
43. Wang W., McLeod H.L., Cassidy J. Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines. Int. J. Cancer 2003, 104:504-511.
44. Wang W., McLeod H.L., Cassidy J., Collie-Duguid E.S. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks. Cancer Chemother. Pharmacol. 2007, 59:839-845.
45. Wohrer S.S., Raderer M., Hejna M. Palliative chemotherapy for advanced gastric cancer. Ann. Oncol. 2004, 15:1585-1595.
46. Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S., Kojiro M. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res. 1994, 54:448-454.
47. Zhang K., Guo Q.L., You Q.D., Yang Y., Zhang H.W., Yang L., Gu H.Y., Qi Q., Tan Z., Wang X. Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up-regulates phospholipid scramblase 1 gene expression. Cancer Sci. 2008, 99:689-695.